» Authors » Nitin S Baliga

Nitin S Baliga

Explore the profile of Nitin S Baliga including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 138
Citations 27466
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Valenzuela J, Immanuel S, Wilson J, Turkarslan S, Ruiz M, Gibbons S, et al.
Nat Commun . 2024 Aug; 15(1):7451. PMID: 39198408
Resource partitioning is central to the incredible productivity of microbial communities, including gigatons in annual methane emissions through syntrophic interactions. Previous work revealed how a sulfate reducer (Desulfovibrio vulgaris, Dv)...
2.
Ludwig C, Howsmon R, Stromholt S, Valenzuela J, Calder R, Baliga N
Humanit Soc Sci Commun . 2024 Jul; 11(1). PMID: 39035098
Consequential STEM experiences in informal settings can address issues of equity by fully engaging historically marginalized high school students in complex socio-scientific issues. However, inclusive and effective programs are in...
3.
Park J, Hothi P, de Lomana A, Pan M, Calder R, Turkarslan S, et al.
Sci Adv . 2024 Jun; 10(23):eadj7706. PMID: 38848360
Poor prognosis and drug resistance in glioblastoma (GBM) can result from cellular heterogeneity and treatment-induced shifts in phenotypic states of tumor cells, including dedifferentiation into glioma stem-like cells (GSCs). This...
4.
Flores-Valdez M, Peterson E, Aceves-Sanchez M, Baliga N, Morita Y, Sparks I, et al.
Sci Rep . 2024 May; 14(1):11898. PMID: 38789479
We have previously reported the transcriptomic and lipidomic profile of the first-generation, hygromycin-resistant (Hyg) version of the BCGΔBCG1419c vaccine candidate, under biofilm conditions. We recently constructed and characterized the efficacy,...
5.
Gupta V, Vaishnavi V, Arrieta-Ortiz M, P S A, K M J, Jeyasankar S, et al.
Adv Healthc Mater . 2024 Apr; 14(5):e2304299. PMID: 38655817
The mortality caused by tuberculosis (TB) infections is a global concern, and there is a need to improve understanding of the disease. Current in vitro infection models to study the...
6.
Murie C, Turkarslan S, Patel A, Coffey D, Becker P, Baliga N
medRxiv . 2024 Apr; PMID: 38633807
Background: Individualized treatment decisions for patients with multiple myeloma (MM) requires accurate risk stratification that takes into account patient-specific consequences of genetic abnormalities and tumor microenvironment on disease outcome and...
7.
Turkarslan S, He Y, Hothi P, Murie C, Nicolas A, Kannan K, et al.
medRxiv . 2024 Apr; PMID: 38633778
Grade IV glioma, formerly known as glioblastoma multiforme (GBM) is the most aggressive and lethal type of brain tumor, and its treatment remains challenging in part due to extensive interpatient...
8.
Hunt K, Carr A, Otwell A, Valenzuela J, Walker K, Dixon E, et al.
Environ Sci Technol . 2024 Apr; 58(16):7056-7065. PMID: 38608141
The sources and sinks of nitrous oxide, as control emissions to the atmosphere, are generally poorly constrained for most environmental systems. Initial depth-resolved analysis of nitrous oxide flux from observation...
9.
Park J, Hothi P, de Lomana A, Pan M, Calder R, Turkarslan S, et al.
bioRxiv . 2024 Feb; PMID: 38370784
Poor prognosis and drug resistance in glioblastoma (GBM) can result from cellular heterogeneity and treatment-induced shifts in phenotypic states of tumor cells, including dedifferentiation into glioma stem-like cells (GSCs). This...
10.
Kusebauch U, Lorenzetti A, Campbell D, Pan M, Shteynberg D, Kapil C, et al.
Sci Data . 2023 Oct; 10(1):697. PMID: 37833331
Data-Independent Acquisition (DIA) is a mass spectrometry-based method to reliably identify and reproducibly quantify large fractions of a target proteome. The peptide-centric data analysis strategy employed in DIA requires a...